서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 45 of 45

Issue DateTitle / Author(s) / CitationFileAltmetrics
2008-05
Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines
link
2008-06
Investigation on health effects of an abandoned metal mine
view fileDOI
2011-09
Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer
DOI
2013-04
Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer
DOI
2014-04
Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma

Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog

Leukemia and Lymphoma, Vol.55 No.4, pp.940-943

DOI
2015-01
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer
2015-05
Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer

Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog

Clinical Cancer Research, Vol.21 No.10, pp.2379-2387

DOI
2015-11
Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells
DOI
2015-12
Mechanisms of Acquired Resistance to AZD9291 A Mutation-Selective, Irreversible EGFR Inhibitor
DOI
2017-05
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type
DOI
2017-09
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
DOI
2017-11
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
DOI
2019-06
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors
DOI
2019-07
Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib

Kim, Seulki; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Alm, Yong-Oon; Keam, Bhumsuk; Heo, Dae Seog

Cancer Research and Treatment, Vol.51 No.3, pp.951-962

DOI
2019-07
Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer
DOI
2019-08
Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study
DOI
2019-09
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations

Lee, Yusoo; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Ku, Ja-Lok; Heo, Dae Seog

Journal of Thoracic Oncology, Vol.14 No.9, pp.1556-1566

DOI
2020
온라인 시장의 가격조정 주기에 관한 실증적 연구 : 온라인 수집가격 빅데이터를 활용하여
view filelink
2020
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
DOI
2020-05
Subjective cognitive decline and subsequent dementia: a nationwide cohort study of 579,710 people aged 66 years in South Korea
view fileDOI
2020-09
Associations between vascular risk factors and subsequent Alzheimers disease in older adults
view fileDOI
2020-12
Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells
DOI
2021-10
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Oh, So Yeon; Kim, Soyeon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog

Scientific Reports, Vol.11 No.1, p. 19712

DOI
2021-11
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR(T790M)-Mutant NSCLC
DOI
2022-01
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
DOI
2022-01
Feasibility of low-dose CT protocols for evaluating the sinonasal cavity and reducing radiation exposure in dogs

Lee, Suhyun; Jang, Seo-Lyn; Kim, Soyeon; Lee, Juryeong; Hyeong, Seongjae; Choi, Jihye

Veterinary Radiology and Ultrasound, Vol.2020 No.7

DOI
2022-03
Review of Pocadius-complex (Coleoptera: Nitidulidae: Nitidulinae) in Korea

Lee, Min Hyeuk; Lee, Ho; Kim, Soyeon; Kim, Taeil; Kim, Hyonam; Lee, Seunghwan

Journal of Asia-Pacific Biodiversity, Vol.15 No.1, pp.40-45

DOI
2022-04
Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types
DOI
2022-07
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
DOI
2022-08
Revisiting the Complications of Orthodontic Miniscrew

Truong, Van Mai; Kim, Soyeon; Kim, Jaeheon; Lee, Joo Won; Park, Young-Seok

BioMed Research International, Vol.2022, p. 8720412

DOI
2022-08
Effect of a nutritional support protocol on enteral nutrition and clinical outcomes of critically ill patients: a retrospective cohort study

Park, Heemoon; Lim, Sung Yoon; Kim, Sebin; Kim, Hyung-Sook; Kim, Soyeon; Yoon, Ho Il; Cho, Young-Jae

Acute and Critical Care, Vol.37 No.3, pp.382-390

DOI
2023-01
The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
DOI
2023-04
Volumetric Absorptive Microsampling for the Therapeutic Drug Monitoring of Everolimus in Patients Who Have Undergone Liver Transplant

Yoo, Seungji; Kim, Giseob; Kim, Soyeon; Ha, Jungeun; Cho, Beom Sik; Joo, Dong Jin; Lee, Jangik I. I.

Therapeutic Drug Monitoring, Vol.45 No.2, pp.223-228

DOI
2023-06
Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance

Kim, Jung Sun; Kim, Soyeon; Koh, Jaemoon; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Lindmark, Bertil; Kim, Dong-Wan

Journal of Cancer Research and Clinical Oncology, Vol.149 No.6, pp.2355-2365

DOI
2023-06
Causal role of the dorsolateral prefrontal cortex in modulating the balance between Pavlovian and instrumental systems in the punishment domain
DOI
2023-08
Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines

Lee, Jeongjae; Keam, Bhumsuk; Park, Ha-Ram; Park, Ji-Eun; Kim, Soyeon; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog

Journal of Cancer Research and Clinical Oncology, Vol.149 No.9, pp.239-260

DOI
2023-09
Effects of a commercial whitening toothpaste containing hydrogen peroxide and citric acid on dentin abrasion and erosion

Kim, Jae-Heon; Kim, Soyeon; Park, Young-Seok

BMC Oral Health, Vol.23(1):619

view fileDOI
2023-10
Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Kim, Miso; Kim, Soyeon; Yim, Jeemin; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog

Cancer Research and Treatment, Vol.55 No.4, pp.1134-1143

DOI
2024
Effects of tea and coffee on tooth discoloration

Kim, Soyeon; Son, Ji Eun; Larnani, Sri; Sim, Hye-Young; Yun, Pil-Young; Kim, Young-Jae; Park, Young-Seok

ITALIAN JOURNAL OF FOOD SCIENCE, Vol.36 No.4, pp.64-71

DOI
2024-01
Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites
DOI
2024-08
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
DOI
2024-09
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
DOI
2024-10
Transcriptomic Heterogeneity of EGFR-Mutant Non–Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
DOI
2024-12
Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development
DOI
2025-02
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
DOI
1